<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03117140</url>
  </required_header>
  <id_info>
    <org_study_id>201304727</org_study_id>
    <nct_id>NCT03117140</nct_id>
  </id_info>
  <brief_title>Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block</brief_title>
  <official_title>A Prospective Triple-masked Randomized Controlled Trial Measuring Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Melinda Seering</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized controlled triple-masked study looking at the duration of
      nerve block analgesia when using the listed adjuvants (dexamethasone, buprenorphine and
      clonidine) plus ropivacaine versus plain ropivacaine alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized controlled triple-masked study looking at the duration of
      nerve block analgesia when using the listed adjuvants (dexamethasone, buprenorphine and
      clonidine) plus ropivacaine versus plain ropivacaine alone. This will be looked on on
      patients undergoing painful shoulder surgery in the ambulatory surgery center. Patients will
      be randomized to one of four groups (1. 0.75% plain ropivacaine. The reference comparator 2.
      A mixture of 0.75% ropivacaine with 300 mcg buprenorphine 3. A mixture of 0.75% ropivacaine
      with 75 mcg clonidine 4. A mixture of 0.75% ropivacaine with and 8mg dexamethasone) for their
      regimen in the interscalene block for their surgery. The patients will then be called within
      3 days post-operatively to follow-up. Follow-up data collected will be when did the patient
      experience return of pain to the operative limb (duration of analgesia), when did the patient
      experience return of motor function of the operative limb (duration of motor block) and when
      did the patient experience return of sensation of the operative limb (return of sensory
      block). All three of these adjuvants have been studied previously and shown to have increased
      analgesic duration with local anesthesia, but have never had a good comparative study. The
      mechanism of action of the analgesia for these adjuvants pain relief has never been shown
      although it is likely a indirect effect as there are animal studies looking at their effect
      on A and C fibers that did not show those results.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Analgesia</measure>
    <time_frame>1-3 days post-operative</time_frame>
    <description>Patients are called 1-3 days post-operatively to assess when the analgesia of their nerve block wore off</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Block Set up Time</measure>
    <time_frame>Day one</time_frame>
    <description>Patients are assessed from needle removal to when they are no longer able to feel cold on the blocked extremity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory Duration of Block</measure>
    <time_frame>Day 1-3</time_frame>
    <description>Patients are called 1-3 days post-operatively to assess when the sensory component of their nerve block wore off</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reporting Vomiting at Home</measure>
    <time_frame>1-3 days</time_frame>
    <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Vomiting in the PACU (Post-Anesthesia Care Unit)</measure>
    <time_frame>Post-op Day 0 (Baseline)</time_frame>
    <description>Vomiting in PACU (Post-Anesthesia Care Unit) for patients was looked at</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Reporting Nausea at Home</measure>
    <time_frame>1-3 days</time_frame>
    <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Reporting Nausea in the PACU</measure>
    <time_frame>Post-op day 0 (Baseline)</time_frame>
    <description>PACU (Post-Anesthesia Care Unit) assessment of nausea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Duration of Block</measure>
    <time_frame>Day 1-3</time_frame>
    <description>Patients are called 1-3 days post-operatively to assess when motor component of their nerve block wore off</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Blood Pressure (BP) Changes in the PACU</measure>
    <time_frame>Post-op Day 0 (baseline)</time_frame>
    <description>Blood pressure changes in PACU (Post-Anesthesia Care Unit) for patients was looked at</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patient With Blood Pressure Changes in the Second Stage Recovery Area</measure>
    <time_frame>Post-op Day 0 (baseline)</time_frame>
    <description>Blood pressure changes in Second Stage Recovery Area for patients was looked at</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Score Reported by Patients at First Phone Call</measure>
    <time_frame>Day 1-3</time_frame>
    <description>Patients are called 1-3 days post-operatively to assess pain. Pain score is 0-10 scale with 0 is no pain and 10 is most severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Reporting Itching in the PACU</measure>
    <time_frame>Post-op day 0 (baseline)</time_frame>
    <description>Patients itching was assessed post-op in the PACU.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Reporting Itching at Home</measure>
    <time_frame>1-3 days</time_frame>
    <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Surgical Position</measure>
    <time_frame>Post-op Day 0 (Baseline)</time_frame>
    <description>Surgical position was recorded</description>
  </other_outcome>
  <other_outcome>
    <measure>Surgical Length</measure>
    <time_frame>Post op Day 0 (Baseline)</time_frame>
    <description>Surgical length was recorded</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Plain Ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine + Buprenorphine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine + Clonidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivaciane + Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.75%</intervention_name>
    <description>Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
    <arm_group_label>Plain Ropivacaine</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.75% + 300 mcg Buprenorphine</intervention_name>
    <description>Ropivacaine 0.75% + 300 mcg Buprenorphine is administered for this arm of the interscalene block</description>
    <arm_group_label>Ropivacaine + Buprenorphine</arm_group_label>
    <other_name>Naropin + Buprenex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.75% + 75 mcg clonidine</intervention_name>
    <description>Ropivacaine 0.75% + 75 mcg Clonidine is administered for this arm of the interscalene block</description>
    <arm_group_label>Ropivacaine + Clonidine</arm_group_label>
    <other_name>Naropin + Duraclon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.75% + 8 mg dexamethasone</intervention_name>
    <description>Ropivacaine 0.75% + 8 mg Dexamethasone is administered for this arm of the interscalene block</description>
    <arm_group_label>Ropivaciane + Dexamethasone</arm_group_label>
    <other_name>Naropin + Decadron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have or are:

               1. Orthopedics service patients having shoulder surgery

               2. ASA(American Society of Anesthesiologists) class I, II, or III.

               3. Patients at least 18 years old but less than 71 years old.

               4. Patients giving informed consent.

               5. Non-Emergency Surgery

                  Exclusion Criteria:

          -  Patients who have or are:

               1. An inability to cooperate during the block placement.

               2. Neuropathy of the planned extremity to block

               3. Diabetes

               4. Documented Kidney Disease

               5. Documented Liver Disease

               6. A lack of or inability to give informed consent.

               7. Currently incarcerated.

               8. Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melinda Seering, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa Hospital and Clinics, Ambulatory Surgery Clinic</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Brummett CM, Williams BA. Additives to local anesthetics for peripheral nerve blockade. Int Anesthesiol Clin. 2011 Fall;49(4):104-16. doi: 10.1097/AIA.0b013e31820e4a49. Review.</citation>
    <PMID>21956081</PMID>
  </reference>
  <reference>
    <citation>Yilmaz-Rastoder E, Gold MS, Hough KA, Gebhart GF, Williams BA. Effect of adjuvant drugs on the action of local anesthetics in isolated rat sciatic nerves. Reg Anesth Pain Med. 2012 Jul-Aug;37(4):403-9. doi: 10.1097/AAP.0b013e3182485965.</citation>
    <PMID>22430023</PMID>
  </reference>
  <reference>
    <citation>Ilfeld BM, Morey TE, Enneking FK. Continuous infraclavicular brachial plexus block for postoperative pain control at home: a randomized, double-blinded, placebo-controlled study. Anesthesiology. 2002 Jun;96(6):1297-304.</citation>
    <PMID>12170039</PMID>
  </reference>
  <reference>
    <citation>Ilfeld BM, Morey TE, Thannikary LJ, Wright TW, Enneking FK. Clonidine added to a continuous interscalene ropivacaine perineural infusion to improve postoperative analgesia: a randomized, double-blind, controlled study. Anesth Analg. 2005 Apr;100(4):1172-8.</citation>
    <PMID>15781540</PMID>
  </reference>
  <reference>
    <citation>Ilfeld BM, Morey TE, Wang RD, Enneking FK. Continuous popliteal sciatic nerve block for postoperative pain control at home: a randomized, double-blinded, placebo-controlled study. Anesthesiology. 2002 Oct;97(4):959-65.</citation>
    <PMID>12357165</PMID>
  </reference>
  <reference>
    <citation>Ilfeld BM, Vandenborne K, Duncan PW, Sessler DI, Enneking FK, Shuster JJ, Theriaque DW, Chmielewski TL, Spadoni EH, Wright TW. Ambulatory continuous interscalene nerve blocks decrease the time to discharge readiness after total shoulder arthroplasty: a randomized, triple-masked, placebo-controlled study. Anesthesiology. 2006 Nov;105(5):999-1007.</citation>
    <PMID>17065895</PMID>
  </reference>
  <reference>
    <citation>White PF, Issioui T, Skrivanek GD, Early JS, Wakefield C. The use of a continuous popliteal sciatic nerve block after surgery involving the foot and ankle: does it improve the quality of recovery? Anesth Analg. 2003 Nov;97(5):1303-9. Erratum in: Anesth Analg. 2003 Dec;97(6):1557.</citation>
    <PMID>14570643</PMID>
  </reference>
  <reference>
    <citation>Capdevila X, Pirat P, Bringuier S, Gaertner E, Singelyn F, Bernard N, Choquet O, Bouaziz H, Bonnet F; French Study Group on Continuous Peripheral Nerve Blocks. Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: a multicenter prospective analysis of the quality of postoperative analgesia and complications in 1,416 patients. Anesthesiology. 2005 Nov;103(5):1035-45.</citation>
    <PMID>16249678</PMID>
  </reference>
  <reference>
    <citation>Saporito A, Sturini E, Petri J, Borgeat A, Aguirre JA. Case report: unusual complication during outpatient continuous regional popliteal analgesia. Can J Anaesth. 2012 Oct;59(10):958-62. Epub 2012 Jul 25.</citation>
    <PMID>22829027</PMID>
  </reference>
  <reference>
    <citation>Candido KD, Franco CD, Khan MA, Winnie AP, Raja DS. Buprenorphine added to the local anesthetic for brachial plexus block to provide postoperative analgesia in outpatients. Reg Anesth Pain Med. 2001 Jul-Aug;26(4):352-6.</citation>
    <PMID>11464356</PMID>
  </reference>
  <reference>
    <citation>Candido KD, Winnie AP, Ghaleb AH, Fattouh MW, Franco CD. Buprenorphine added to the local anesthetic for axillary brachial plexus block prolongs postoperative analgesia. Reg Anesth Pain Med. 2002 Mar-Apr;27(2):162-7.</citation>
    <PMID>11915063</PMID>
  </reference>
  <reference>
    <citation>Candido KD, Hennes J, Gonzalez S, Mikat-Stevens M, Pinzur M, Vasic V, Knezevic NN. Buprenorphine enhances and prolongs the postoperative analgesic effect of bupivacaine in patients receiving infragluteal sciatic nerve block. Anesthesiology. 2010 Dec;113(6):1419-26. doi: 10.1097/ALN.0b013e3181f90ce8.</citation>
    <PMID>21042200</PMID>
  </reference>
  <reference>
    <citation>Cummings KC 3rd, Napierkowski DE, Parra-Sanchez I, Kurz A, Dalton JE, Brems JJ, Sessler DI. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. Br J Anaesth. 2011 Sep;107(3):446-53. doi: 10.1093/bja/aer159. Epub 2011 Jun 14.</citation>
    <PMID>21676892</PMID>
  </reference>
  <reference>
    <citation>Vieira PA, Pulai I, Tsao GC, Manikantan P, Keller B, Connelly NR. Dexamethasone with bupivacaine increases duration of analgesia in ultrasound-guided interscalene brachial plexus blockade. Eur J Anaesthesiol. 2010 Mar;27(3):285-8. doi: 10.1097/EJA.0b013e3283350c38.</citation>
    <PMID>20009936</PMID>
  </reference>
  <reference>
    <citation>Kim YJ, Lee GY, Kim DY, Kim CH, Baik HJ, Heo S. Dexamathasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean J Anesthesiol. 2012 Feb;62(2):130-4. doi: 10.4097/kjae.2012.62.2.130. Epub 2012 Feb 20.</citation>
    <PMID>22379567</PMID>
  </reference>
  <reference>
    <citation>Movafegh A, Razazian M, Hajimaohamadi F, Meysamie A. Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesth Analg. 2006 Jan;102(1):263-7.</citation>
    <PMID>16368840</PMID>
  </reference>
  <reference>
    <citation>Casati A, Magistris L, Fanelli G, Beccaria P, Cappelleri G, Aldegheri G, Torri G. Small-dose clonidine prolongs postoperative analgesia after sciatic-femoral nerve block with 0.75% ropivacaine for foot surgery. Anesth Analg. 2000 Aug;91(2):388-92.</citation>
    <PMID>10910854</PMID>
  </reference>
  <reference>
    <citation>Couture DJ, Cuniff HM, Maye JP, Pellegrini J. The addition of clonidine to bupivacaine in combined femoral-sciatic nerve block for anterior cruciate ligament reconstruction. AANA J. 2004 Aug;72(4):273-8.</citation>
    <PMID>15354916</PMID>
  </reference>
  <reference>
    <citation>Duma A, Urbanek B, Sitzwohl C, Kreiger A, Zimpfer M, Kapral S. Clonidine as an adjuvant to local anaesthetic axillary brachial plexus block: a randomized, controlled study. Br J Anaesth. 2005 Jan;94(1):112-6. Epub 2004 Oct 29.</citation>
    <PMID>15516351</PMID>
  </reference>
  <reference>
    <citation>Sripada R, Bowens C Jr. Regional anesthesia procedures for shoulder and upper arm surgery upper extremity update--2005 to present. Int Anesthesiol Clin. 2012 Winter;50(1):26-46. doi: 10.1097/AIA.0b013e31821a0284. Review.</citation>
    <PMID>22227421</PMID>
  </reference>
  <reference>
    <citation>Williams BA. Forecast for perineural analgesia procedures for ambulatory surgery of the knee, foot, and ankle: applying patient-centered paradigm shifts. Int Anesthesiol Clin. 2012 Winter;50(1):126-42. doi: 10.1097/AIA.0b013e31821a00d0.</citation>
    <PMID>22227428</PMID>
  </reference>
  <reference>
    <citation>Williams BA, Hough KA, Tsui BY, Ibinson JW, Gold MS, Gebhart GF. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011 May-Jun;36(3):225-30. doi: 10.1097/AAP.0b013e3182176f70.</citation>
    <PMID>21519308</PMID>
  </reference>
  <reference>
    <citation>Ahadian FM, McGreevy K, Schulteis G. Lumbar transforaminal epidural dexamethasone: a prospective, randomized, double-blind, dose-response trial. Reg Anesth Pain Med. 2011 Nov-Dec;36(6):572-8. doi: 10.1097/AAP.0b013e318232e843.</citation>
    <PMID>22005659</PMID>
  </reference>
  <reference>
    <citation>Bonhomme V, Doll A, Dewandre PY, Brichant JF, Ghassempour K, Hans P. Epidural administration of low-dose morphine combined with clonidine for postoperative analgesia after lumbar disc surgery. J Neurosurg Anesthesiol. 2002 Jan;14(1):1-6.</citation>
    <PMID>11773815</PMID>
  </reference>
  <reference>
    <citation>Vuković J, Ramakrishnan P, Milan Z. Does epidural clonidine improve postoperative analgesia in major vascular surgery? Med Glas (Zenica). 2012 Feb;9(1):49-55.</citation>
    <PMID>22634908</PMID>
  </reference>
  <reference>
    <citation>Walker SM, Yaksh TL. Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data. Anesth Analg. 2012 Sep;115(3):638-62. doi: 10.1213/ANE.0b013e31826253f2. Epub 2012 Jul 13. Review.</citation>
    <PMID>22798528</PMID>
  </reference>
  <reference>
    <citation>Kawamoto S, Tatsumi K, Kataoka T, Kamikawa T, Yanagida T, Mandai R. [Comparison of intrathecal morphine and buprenorphine for postoperative analgesia in cesarean delivery]. Masui. 2011 Aug;60(8):892-6. Japanese.</citation>
    <PMID>21861411</PMID>
  </reference>
  <reference>
    <citation>Modi M, Rastogi S, Kumar A. Buprenorphine with bupivacaine for intraoral nerve blocks to provide postoperative analgesia in outpatients after minor oral surgery. J Oral Maxillofac Surg. 2009 Dec;67(12):2571-6. doi: 10.1016/j.joms.2009.07.014.</citation>
    <PMID>19925973</PMID>
  </reference>
  <reference>
    <citation>Ip VH, Tsui BC. Practical concepts in the monitoring of injection pressures during peripheral nerve blocks. Int Anesthesiol Clin. 2011 Fall;49(4):67-80. doi: 10.1097/AIA.0b013e31821775bc. Review.</citation>
    <PMID>21956078</PMID>
  </reference>
  <reference>
    <citation>Tsui BC, Li LX, Pillay JJ. Compressed air injection technique to standardize block injection pressures. Can J Anaesth. 2006 Nov;53(11):1098-102.</citation>
    <PMID>17079636</PMID>
  </reference>
  <reference>
    <citation>Auroy Y, Benhamou D, Bargues L, Ecoffey C, Falissard B, Mercier FJ, Bouaziz H, Samii K. Major complications of regional anesthesia in France: The SOS Regional Anesthesia Hotline Service. Anesthesiology. 2002 Nov;97(5):1274-80. Erratum in: Anesthesiology. 2003 Feb;98(2):595. Mercier Frédéric [corrected to Mercier Frédéric J].</citation>
    <PMID>12411815</PMID>
  </reference>
  <reference>
    <citation>Neal JM, Bernards CM, Hadzic A, Hebl JR, Hogan QH, Horlocker TT, Lee LA, Rathmell JP, Sorenson EJ, Suresh S, Wedel DJ. ASRA Practice Advisory on Neurologic Complications in Regional Anesthesia and Pain Medicine. Reg Anesth Pain Med. 2008 Sep-Oct;33(5):404-15. doi: 10.1016/j.rapm.2008.07.527.</citation>
    <PMID>18774509</PMID>
  </reference>
  <reference>
    <citation>Laur JJ, Chehade JM, Merrill DG. Managing neural dysfunction after regional anesthesia: experience in a walk-in follow-up clinic. Int Anesthesiol Clin. 2011 Summer;49(3):44-55. doi: 10.1097/AIA.0b013e318217fe85.</citation>
    <PMID>21697669</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>April 11, 2017</study_first_submitted>
  <study_first_submitted_qc>April 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2017</study_first_posted>
  <results_first_submitted>April 17, 2018</results_first_submitted>
  <results_first_submitted_qc>July 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">July 3, 2018</results_first_posted>
  <last_update_submitted>July 2, 2018</last_update_submitted>
  <last_update_submitted_qc>July 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Melinda Seering</investigator_full_name>
    <investigator_title>Clinical Assistant Profession, Prinicipal Investigator</investigator_title>
  </responsible_party>
  <keyword>Brachial Plexus Block</keyword>
  <keyword>Clonidine</keyword>
  <keyword>Dexamethasone</keyword>
  <keyword>Buprenorphine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Buprenorphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 18, 2012</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/40/NCT03117140/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Plain Ropiviciane</title>
          <description>Plain Ropivicaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivicaine 0.75%: Only ropivicaine 0.75% is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="P2">
          <title>Ropiviciane + Buprenorphine</title>
          <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivicaine 0.75% + 300 mcg Buprenorphine: Ropivicaine 0.75% + 300 mcg Buprenorphine is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="P3">
          <title>Ropivicaine + Clonidine</title>
          <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivicaine 0.75% + 75 mcg clonidine: Ropivicaine 0.75% + 75 mcg Clonidine is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="P4">
          <title>Ropiviciane + Dexamethasone</title>
          <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivicaine 0.75% + 8 mg dexamethasone: Ropivicaine 0.75% + 8 mg Dexamethasone is administered for this arm of the interscalene block</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
                <participants group_id="P4" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="40"/>
                <participants group_id="P4" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Plain Ropivacaine</title>
          <description>Plain ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="B2">
          <title>Ropivacaine + Buprenorphine</title>
          <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="B3">
          <title>Ropivacaine + Clonidine</title>
          <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="B4">
          <title>Ropivacaine + Dexamethasone</title>
          <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="40"/>
            <count group_id="B4" value="40"/>
            <count group_id="B5" value="160"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="40"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="39"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="154"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="40"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.38" spread="14.39"/>
                    <measurement group_id="B2" value="44.8" spread="14.2"/>
                    <measurement group_id="B3" value="43.1" spread="14.74"/>
                    <measurement group_id="B4" value="42.3" spread="13.71"/>
                    <measurement group_id="B5" value="43.89" spread="14.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="40"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="31"/>
                    <measurement group_id="B5" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA (American Society of Anesthesiolgy) Classification system</title>
          <description>I-a normal healthy patient II- a patient with mild systemic disease III-a patient with severe systemic disease</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ASA classification I</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="40"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="17"/>
                    <measurement group_id="B5" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA classification II</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="40"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA classification III</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="40"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="40"/>
                    <count group_id="B2" value="40"/>
                    <count group_id="B3" value="40"/>
                    <count group_id="B4" value="40"/>
                    <count group_id="B5" value="160"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="98.82" spread="22.71"/>
                    <measurement group_id="B2" value="98.13" spread="21.47"/>
                    <measurement group_id="B3" value="99.78" spread="25.95"/>
                    <measurement group_id="B4" value="95.63" spread="21.41"/>
                    <measurement group_id="B5" value="98.09" spread="22.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Duration of Analgesia</title>
        <description>Patients are called 1-3 days post-operatively to assess when the analgesia of their nerve block wore off</description>
        <time_frame>1-3 days post-operative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg Buprenorphine: Ropivacaine 0.75% + 300 mcg Buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Analgesia</title>
          <description>Patients are called 1-3 days post-operatively to assess when the analgesia of their nerve block wore off</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="911" lower_limit="652" upper_limit="1300"/>
                    <measurement group_id="O2" value="1026.5" lower_limit="756.5" upper_limit="1392.5"/>
                    <measurement group_id="O3" value="1181" lower_limit="880.5" upper_limit="1528.5"/>
                    <measurement group_id="O4" value="982" lower_limit="799" upper_limit="1270"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Block Set up Time</title>
        <description>Patients are assessed from needle removal to when they are no longer able to feel cold on the blocked extremity</description>
        <time_frame>Day one</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg Buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Block Set up Time</title>
          <description>Patients are assessed from needle removal to when they are no longer able to feel cold on the blocked extremity</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O2" value="3" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="O3" value="6" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="O4" value="4.5" lower_limit="3" upper_limit="10.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sensory Duration of Block</title>
        <description>Patients are called 1-3 days post-operatively to assess when the sensory component of their nerve block wore off</description>
        <time_frame>Day 1-3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Sensory Duration of Block</title>
          <description>Patients are called 1-3 days post-operatively to assess when the sensory component of their nerve block wore off</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="923.5" lower_limit="652" upper_limit="1304"/>
                    <measurement group_id="O2" value="982" lower_limit="705" upper_limit="1189"/>
                    <measurement group_id="O3" value="940.5" lower_limit="736.5" upper_limit="1234"/>
                    <measurement group_id="O4" value="1066" lower_limit="797" upper_limit="1240"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Reporting Vomiting at Home</title>
        <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
        <time_frame>1-3 days</time_frame>
        <population>1 patient in the Plain Ropivacaine group and the Ropivacaine and Buprenorphine group did not complete the survey about vomiting at home and therefore was not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Reporting Vomiting at Home</title>
          <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
          <population>1 patient in the Plain Ropivacaine group and the Ropivacaine and Buprenorphine group did not complete the survey about vomiting at home and therefore was not included in the analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Vomiting in the PACU (Post-Anesthesia Care Unit)</title>
        <description>Vomiting in PACU (Post-Anesthesia Care Unit) for patients was looked at</description>
        <time_frame>Post-op Day 0 (Baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Vomiting in the PACU (Post-Anesthesia Care Unit)</title>
          <description>Vomiting in PACU (Post-Anesthesia Care Unit) for patients was looked at</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Reporting Nausea at Home</title>
        <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
        <time_frame>1-3 days</time_frame>
        <population>1 patient in the Plain Ropivacaine group and the Ropivacaine and Buprenorphine group did not complete the survey about nausea at home and therefore was not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Reporting Nausea at Home</title>
          <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
          <population>1 patient in the Plain Ropivacaine group and the Ropivacaine and Buprenorphine group did not complete the survey about nausea at home and therefore was not included in the analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Reporting Nausea in the PACU</title>
        <description>PACU (Post-Anesthesia Care Unit) assessment of nausea</description>
        <time_frame>Post-op day 0 (Baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Reporting Nausea in the PACU</title>
          <description>PACU (Post-Anesthesia Care Unit) assessment of nausea</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Motor Duration of Block</title>
        <description>Patients are called 1-3 days post-operatively to assess when motor component of their nerve block wore off</description>
        <time_frame>Day 1-3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivicaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Motor Duration of Block</title>
          <description>Patients are called 1-3 days post-operatively to assess when motor component of their nerve block wore off</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1120" lower_limit="748" upper_limit="1484"/>
                    <measurement group_id="O2" value="1198" lower_limit="835" upper_limit="1406"/>
                    <measurement group_id="O3" value="1090" lower_limit="829" upper_limit="1526"/>
                    <measurement group_id="O4" value="1143.5" lower_limit="949.5" upper_limit="1356.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Blood Pressure (BP) Changes in the PACU</title>
        <description>Blood pressure changes in PACU (Post-Anesthesia Care Unit) for patients was looked at</description>
        <time_frame>Post-op Day 0 (baseline)</time_frame>
        <population>1 patient in Ropivacaine and Buprenorphine group did get data for the BP changes in the PACU for the study so therefore was not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Blood Pressure (BP) Changes in the PACU</title>
          <description>Blood pressure changes in PACU (Post-Anesthesia Care Unit) for patients was looked at</description>
          <population>1 patient in Ropivacaine and Buprenorphine group did get data for the BP changes in the PACU for the study so therefore was not included in the analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patient With Blood Pressure Changes in the Second Stage Recovery Area</title>
        <description>Blood pressure changes in Second Stage Recovery Area for patients was looked at</description>
        <time_frame>Post-op Day 0 (baseline)</time_frame>
        <population>1 patient in Ropivacaine and Buprenorphine group did not have blood pressure data obtained in the second stage area so therefore was not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient With Blood Pressure Changes in the Second Stage Recovery Area</title>
          <description>Blood pressure changes in Second Stage Recovery Area for patients was looked at</description>
          <population>1 patient in Ropivacaine and Buprenorphine group did not have blood pressure data obtained in the second stage area so therefore was not included in the analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Score Reported by Patients at First Phone Call</title>
        <description>Patients are called 1-3 days post-operatively to assess pain. Pain score is 0-10 scale with 0 is no pain and 10 is most severe pain.</description>
        <time_frame>Day 1-3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score Reported by Patients at First Phone Call</title>
          <description>Patients are called 1-3 days post-operatively to assess pain. Pain score is 0-10 scale with 0 is no pain and 10 is most severe pain.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O2" value="3" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="O3" value="4" lower_limit="2" upper_limit="5.5"/>
                    <measurement group_id="O4" value="3" lower_limit="2" upper_limit="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Reporting Itching in the PACU</title>
        <description>Patients itching was assessed post-op in the PACU.</description>
        <time_frame>Post-op day 0 (baseline)</time_frame>
        <population>1 patient in the Ropivacaine and Buprenorphine group did not obtain data on the itching in the PACU therefore was not included in the analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Reporting Itching in the PACU</title>
          <description>Patients itching was assessed post-op in the PACU.</description>
          <population>1 patient in the Ropivacaine and Buprenorphine group did not obtain data on the itching in the PACU therefore was not included in the analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Reporting Itching at Home</title>
        <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
        <time_frame>1-3 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Reporting Itching at Home</title>
          <description>Patients are called 1-3 days post-operatively to assess if they had any side effects of the adjuvants such as nausea, vomiting or itching. There blood pressure is looked at pre-op and compared to post-op. Any prolonged PACU (Post Anesthesia Care Unit) stay for sedation is recorded.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Surgical Position</title>
        <description>Surgical position was recorded</description>
        <time_frame>Post-op Day 0 (Baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Position</title>
          <description>Surgical position was recorded</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Beach Chair</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lateral</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Supine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Surgical Length</title>
        <description>Surgical length was recorded</description>
        <time_frame>Post op Day 0 (Baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Plain Ropivacaine</title>
            <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O2">
            <title>Ropivacaine + Buprenorphine</title>
            <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O3">
            <title>Ropivacaine + Clonidine</title>
            <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
          </group>
          <group group_id="O4">
            <title>Ropivacaine + Dexamethasone</title>
            <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
          </group>
        </group_list>
        <measure>
          <title>Surgical Length</title>
          <description>Surgical length was recorded</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="40"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.5" lower_limit="45" upper_limit="94"/>
                    <measurement group_id="O2" value="65" lower_limit="49" upper_limit="87.5"/>
                    <measurement group_id="O3" value="73.5" lower_limit="56" upper_limit="101"/>
                    <measurement group_id="O4" value="71" lower_limit="47.5" upper_limit="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse advents data was collected from Day 1 until Day 3 when the phone call was made. We do have a post-block clinic where patients with adverse events post-block are seen. None from the study were seen here.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Plain Ropivacaine</title>
          <description>Plain Ropivacaine 0.75%, (225 mg) total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75%: Only ropivacaine 0.75% is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="E2">
          <title>Ropivacaine + Buprenorphine</title>
          <description>A mixture of 0.75% ropivacaine with 300 mcg buprenorphine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 300 mcg buprenorphine: Ropivacaine 0.75% + 300 mcg buprenorphine is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="E3">
          <title>Ropivacaine + Clonidine</title>
          <description>A mixture of 0.75% ropivacaine with 75 mcg clonidine, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 75 mcg clonidine: Ropivacaine 0.75% + 75 mcg clonidine is administered for this arm of the interscalene block</description>
        </group>
        <group group_id="E4">
          <title>Ropivacaine + Dexamethasone</title>
          <description>A mixture of 0.75% ropivacaine with and 8 mg dexamethasone, total volume 32 cc for interscalene block given pre-operatively
Ropivacaine 0.75% + 8 mg dexamethasone: Ropivacaine 0.75% + 8 mg dexamethasone is administered for this arm of the interscalene block</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Melinda Seering</name_or_title>
      <organization>Univesity of Iowa Hospitals and Clinics</organization>
      <phone>3193561616</phone>
      <email>melinda-seering@uiowa.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

